These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 9592977)
1. P-glycoprotein (PGP), and not lung resistance-related protein (LRP), is a negative prognostic factor in secondary leukemias. Damiani D; Michieli M; Ermacora A; Candoni A; Raspadori D; Geromin A; Stocchi R; Grimaz S; Masolini P; Michelutti A; Scheper RJ; Baccarani M Haematologica; 1998 Apr; 83(4):290-7. PubMed ID: 9592977 [TBL] [Abstract][Full Text] [Related]
2. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954 [TBL] [Abstract][Full Text] [Related]
3. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336 [TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells. Michieli M; Damiani D; Ermacora A; Raspadori D; Michelutti A; Grimaz S; Fanin R; Russo D; Lauria F; Masolini P; Baccarani M Br J Haematol; 1997 Feb; 96(2):356-65. PubMed ID: 9029025 [TBL] [Abstract][Full Text] [Related]
5. Antibody binding capacity for evaluation of MDR-related proteins in acute promyelocytic leukemia: Onset versus relapse expression. Damiani D; Michieli M; Michelutti A; Candoni A; Stocchi R; Masolini P; Geromin A; Michelutti T; Raspadori D; Ippoliti M; Lauria F; Fanin R Cytometry B Clin Cytom; 2004 May; 59(1):40-5. PubMed ID: 15108169 [TBL] [Abstract][Full Text] [Related]
6. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome. Raspadori D; Damiani D; Michieli M; Stocchi R; Gentili S; Gozzetti A; Masolini P; Michelutti A; Geromin A; Fanin R; Lauria F Haematologica; 2002 Nov; 87(11):1135-40. PubMed ID: 12414342 [TBL] [Abstract][Full Text] [Related]
7. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes. Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991 [TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein, lung resistance-related protein and multidrug resistance associated protein in de novo acute non-lymphocytic leukaemias: biological and clinical implications. Michieli M; Damiani D; Ermacora A; Masolini P; Raspadori D; Visani G; Scheper RJ; Baccarani M Br J Haematol; 1999 Feb; 104(2):328-35. PubMed ID: 10050716 [TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein expression and prognostic value in acute myeloid leukemia. Senent L; Jarque I; Martín G; Sempere A; González-García Y; Gomis F; Pérez-Sirvent M; De La Rubia J; Sanz MA Haematologica; 1998 Sep; 83(9):783-7. PubMed ID: 9825574 [TBL] [Abstract][Full Text] [Related]
10. A unique human ovarian carcinoma cell line expressing CD34 in association with selection for multidrug resistance. Minderman H; Vanhoefer U; Toth K; Minderman MD; Rustum YM Cancer; 1996 Dec; 78(11):2427-36. PubMed ID: 8941015 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins. Candoni A; Michelutti A; Simeone E; Damiani D; Baccarani M; Fanin R Eur J Haematol; 2006 Oct; 77(4):293-9. PubMed ID: 16856922 [TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells. Borg AG; Burgess R; Green LM; Scheper RJ; Liu Yin JA Br J Haematol; 2000 Jan; 108(1):48-54. PubMed ID: 10651723 [TBL] [Abstract][Full Text] [Related]
13. [Detection of glutathione S-transferase and lung resistance-related proteins in acute leukemia and its clinical significance]. Zhang ZM; Xie ZX; Tan DR; Huang CH Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 30(3):292-4. PubMed ID: 16045016 [TBL] [Abstract][Full Text] [Related]
14. [Expression of lung resistance protein and multidrug resistance-associated protein in naive childhood acute leukemia and their clinical significance]. Zhang JB; Sun Y; Dong J; Liu LX; Ning F Ai Zheng; 2005 Aug; 24(8):1015-7. PubMed ID: 16086885 [TBL] [Abstract][Full Text] [Related]
15. The role of MDR-related proteins in the prognosis of adult acute myeloid leukaemia (AML) with normal karyotype. Damiani D; Tiribelli M; Raspadori D; Michelutti A; Gozzetti A; Calistri E; Candoni A; Chiarvesio A; Lenoci M; Russo D; Fanin R Hematol Oncol; 2007 Mar; 25(1):38-43. PubMed ID: 17200981 [TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic value of the lung resistance-related protein (LRP) in germ cell testicular tumors. Mándoky L; Géczi L; Doleschall Z; Bodrogi I; Csuka O; Kásler M; Bak M Anticancer Res; 2004; 24(2C):1097-104. PubMed ID: 15154630 [TBL] [Abstract][Full Text] [Related]
17. [Sodium butyrate-induced expression of lung resistance-related gene in human myeloid leukemia K562 cells]. Li N; Qian XH; Yao YM; Wang ZY Ai Zheng; 2003 Aug; 22(8):821-5. PubMed ID: 12917027 [TBL] [Abstract][Full Text] [Related]
18. Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias--correlation to the expression of multidrug resistance proteins. Fichtner I; Paal K; Borgmann A; Badiali L; Wurm R; Henze G Anticancer Res; 2003; 23(3B):2657-64. PubMed ID: 12894554 [TBL] [Abstract][Full Text] [Related]
19. Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia? Broxterman HJ; Sonneveld P; Pieters R; Lankelma J; Eekman CA; Loonen AH; Schoester M; Ossenkoppele GJ; Löwenberg B; Pinedo HM; Schuurhuis GJ Leukemia; 1999 Feb; 13(2):258-65. PubMed ID: 10025900 [TBL] [Abstract][Full Text] [Related]
20. Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia. Russo D; Piccaluga PP; Michieli M; Michelutti T; Visani G; Gugliotta L; Bonini A; Pierri I; Gobbi M; Tiribelli M; Fanin R; Piccolrovazzi S; Baccarani M Ann Hematol; 2002 Aug; 81(8):462-6. PubMed ID: 12224004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]